FIELD: medicine, pharmacy. SUBSTANCE: invention relates to agents eliciting an antibacterial effect. Composition is made as a capsule. Composition comprises, g per 1 capsule: azithromycin dihydrate, 0.2682; calcium stearate, 0.0080; maize starch, 0.04; microcrystalline cellulose, 0.0338. This ratio of components is optimal and provides the necessary quality of composition. Invention can be used for treatment of upper and lower respiratory ways, urinary way, skin infections and soft tissues. EFFECT: expanded assortment of antibacterial preparations, valuable medicinal properties of composition. 1 dwg, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| INJECTION ANTIBACTERIAL PHARMACEUTICAL COMPOSITION | 2014 |
|
RU2563826C1 |
| ANTIBIOTIC SUMAZID | 2001 |
|
RU2212242C1 |
| METHOD FOR PRODUCING COMPOSITION AND COMPOSITION SHOWING ANTIBACTERIAL ACTIVITY | 2001 |
|
RU2182825C1 |
| PHARMACEUTICAL COMPOSITION OF 4-(3-ETHOXY-4-HYDROXYBENZYL)-5-OXO-5,6-DIHYDRO-4H-[1,3,4]-THIADIAZIN-2-(2,4-DIFLUOROPHENYL) CARBOXAMIDE IN CRYSTALLINE FORM , AND USE THEREOF AS ANTIBACTERIAL AGENT FOR TREATING ACUTE, RECURRENT AND CHRONIC INFECTIONS | 2020 |
|
RU2737087C1 |
| SOLID DOSAGE FORM OF AZITHROMYCIN | 2012 |
|
RU2498805C1 |
| PHARMACEUTIC COMPOSITION, POSSESSING ANTIBACTERIAL, ANTIVIRAL AND ANTIFUNGAL ACTION | 2010 |
|
RU2437647C2 |
| MEDICINAL AGENT BRILID WITH ANTIBIOTIC EFFECT | 2001 |
|
RU2207120C1 |
| STABLE PHARMACEUTICAL AZITHROMYCIN SUSPENSION AND METHOD FOR ITS PREPARING | 2003 |
|
RU2255730C1 |
| CONTROLLED-RELEASE PHARMACEUTICAL PROXODOLOL COMPOSITION | 2007 |
|
RU2356532C2 |
| SOLID DISPERSION of 4- (3-ETHOXY-4-HYDROXIBENZIL) -5-OXO-5,6-DIHYDRO-4H- [1,3,4] -THIADIAZINE-2- (2,4-DIFLUOROPHENYL) -CARBOXAMIDE FOR PRODUCING PHARMACEUTICAL FORMULATION AND METHOD OF TREATMENT OF CHRONIC INFECTIOUS DISEASES | 2020 |
|
RU2743927C1 |
